Market Cap 413.65M
Revenue (ttm) 0.00
Net Income (ttm) -49.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 705,700
Avg Vol 1,047,884
Day's Range N/A - N/A
Shares Out 31.29M
Stochastic %K 93%
Beta 0.50
Analysts Strong Sell
Price Target $50.17

Company Profile

LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, Cal...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 925 7000
Address:
201 Lomas Santa Fe Drive, Suite 300, Solana Beach, United States
dbears729
dbears729 Feb. 26 at 10:43 PM
$LENZ lots of Vizz-ability for Lenz at the TD Cowen 46th Annual Health Care Conference with the big boys on Monday. Yoooolo $MRK $PFE
0 · Reply
Max_Regards
Max_Regards Feb. 26 at 8:16 PM
$LENZ short interest as of Jan 30th was 40% 😳 Shorts about to get burned bad 😎
1 · Reply
SirRahal
SirRahal Feb. 26 at 7:48 PM
0 · Reply
CrocksAndPonds
CrocksAndPonds Feb. 26 at 7:47 PM
$LENZ How about give me 13.50 today and about 14 tomorrow, and I can have a good weekend.
0 · Reply
SirRahal
SirRahal Feb. 26 at 2:41 PM
$LENZ Our goal for today, is to end above 13.20. That would be gravy.... I could see this staying sideways today too, so let's hope that stays green.
2 · Reply
NYTWben
NYTWben Feb. 26 at 2:38 PM
$LENZ market selling off, but it looks like we are holding fingers crossed.
0 · Reply
Dreamit2
Dreamit2 Feb. 25 at 8:50 PM
$LENZ If every one of those people that viewed the Jimmy Kimball commercial got a prescription, that would amount to over two hundred and forty eight million dollars , and since drops are high margin that would amount to over two hundred million dollars for Vizz.
1 · Reply
SirRahal
SirRahal Feb. 25 at 2:08 PM
$LENZ game plan today: Stay green, push through 3.30 with volume, and light up the short sellers.
4 · Reply
tomorrowsglory
tomorrowsglory Feb. 24 at 11:30 PM
0 · Reply
NYTWben
NYTWben Feb. 24 at 3:53 PM
$LENZ are the insiders buying again, knowing that they’re gonna release good sales information at the upcoming investor conferences?
2 · Reply
Latest News on LENZ
LENZ Therapeutics to Present at Upcoming Investor Conferences

Feb 23, 2026, 8:00 AM EST - 3 days ago

LENZ Therapeutics to Present at Upcoming Investor Conferences


LENZ Therapeutics: Was That A Market Overreaction?

Dec 17, 2025, 9:02 AM EST - 2 months ago

LENZ Therapeutics: Was That A Market Overreaction?


LENZ Therapeutics, Inc. (LENZ) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 1:21 PM EST - 4 months ago

LENZ Therapeutics, Inc. (LENZ) Q3 2025 Earnings Call Transcript


LENZ Therapeutics: Undervalued Ahead Of PDUFA

Jul 29, 2025, 1:32 PM EDT - 7 months ago

LENZ Therapeutics: Undervalued Ahead Of PDUFA


LENZ Therapeutics: Presbyopia Eyedrops Look Promising

Jul 1, 2025, 4:23 PM EDT - 8 months ago

LENZ Therapeutics: Presbyopia Eyedrops Look Promising


LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript

May 9, 2025, 10:33 AM EDT - 10 months ago

LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript


LENZ Therapeutics: Freedom From Reading Glasses

Apr 7, 2025, 8:00 AM EDT - 11 months ago

LENZ Therapeutics: Freedom From Reading Glasses


LENZ Therapeutics Stock Is Attractive Before PDUFA

Mar 27, 2025, 5:33 PM EDT - 1 year ago

LENZ Therapeutics Stock Is Attractive Before PDUFA


LENZ Therapeutics to Host Commercial Day on April 15, 2025

Mar 3, 2025, 8:00 AM EST - 1 year ago

LENZ Therapeutics to Host Commercial Day on April 15, 2025


Lucy Therapeutics Appoints Kim Drapkin as Board Chair

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

ABOS


LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks

Aug 30, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks


dbears729
dbears729 Feb. 26 at 10:43 PM
$LENZ lots of Vizz-ability for Lenz at the TD Cowen 46th Annual Health Care Conference with the big boys on Monday. Yoooolo $MRK $PFE
0 · Reply
Max_Regards
Max_Regards Feb. 26 at 8:16 PM
$LENZ short interest as of Jan 30th was 40% 😳 Shorts about to get burned bad 😎
1 · Reply
SirRahal
SirRahal Feb. 26 at 7:48 PM
0 · Reply
CrocksAndPonds
CrocksAndPonds Feb. 26 at 7:47 PM
$LENZ How about give me 13.50 today and about 14 tomorrow, and I can have a good weekend.
0 · Reply
SirRahal
SirRahal Feb. 26 at 2:41 PM
$LENZ Our goal for today, is to end above 13.20. That would be gravy.... I could see this staying sideways today too, so let's hope that stays green.
2 · Reply
NYTWben
NYTWben Feb. 26 at 2:38 PM
$LENZ market selling off, but it looks like we are holding fingers crossed.
0 · Reply
Dreamit2
Dreamit2 Feb. 25 at 8:50 PM
$LENZ If every one of those people that viewed the Jimmy Kimball commercial got a prescription, that would amount to over two hundred and forty eight million dollars , and since drops are high margin that would amount to over two hundred million dollars for Vizz.
1 · Reply
SirRahal
SirRahal Feb. 25 at 2:08 PM
$LENZ game plan today: Stay green, push through 3.30 with volume, and light up the short sellers.
4 · Reply
tomorrowsglory
tomorrowsglory Feb. 24 at 11:30 PM
0 · Reply
NYTWben
NYTWben Feb. 24 at 3:53 PM
$LENZ are the insiders buying again, knowing that they’re gonna release good sales information at the upcoming investor conferences?
2 · Reply
Dreamit2
Dreamit2 Feb. 24 at 3:49 PM
$LENZ If all those people that viewed the commercial on Jimmy Kimball got a prescription, it would amount to about 240 million at this point.
0 · Reply
SirRahal
SirRahal Feb. 24 at 3:14 PM
$LENZ Moment of truth, does this pop have any momentum? If this breaks above 12.75 shorts will start covering fast. This could jump to 15 over the next couple of days.
3 · Reply
Max_Regards
Max_Regards Feb. 24 at 12:52 PM
$LENZ nice they have investor conferences planned. However last time they did this they only rehashed existing information so I would not listen to these expecting new insight.
5 · Reply
LUCKYbug
LUCKYbug Feb. 23 at 10:17 PM
2 · Reply
dbears729
dbears729 Feb. 23 at 7:03 PM
$LENZ real talk from the experts. A lot of great gems in this video 4:40 - Dr Jasper excited to start prescribing this in Florida 9:00 - Dr Davidson calling “this is a different type of vision” and it’s “wonderful” 15:00 Dr Bloomenstein “it’s amazing and I call it a lifestyle drop” 15:50 - how it’s different from existing products 41:00 Dr Davidson - “it’s been an economic boom for my practice.” Upcoming Opthalmologist conferences where this will be buzzing: April 10 - ASCRS May 3 - ARVO It’s heating up! Word of mouth taking off, doctors expanding their revenue and it’s improving people’s lifestyles! 😳😳😳 https://youtu.be/WpwwciO6ApY?si=ykXJ1eW4GycgzQ0E
1 · Reply
Max_Regards
Max_Regards Feb. 23 at 4:46 PM
$LENZ yall ever notice our neighborhood friendly short seller Nico never comments on the weekend or outside normal office hours? It’s almost like he may be employed by someone to spread his message of fear and uncertainty. Makes one think. 🤔
3 · Reply
NYTWben
NYTWben Feb. 23 at 2:44 PM
$LENZ they just announced several March investor conferences. We should get some good information on how sales are going.
0 · Reply
philipv777
philipv777 Feb. 23 at 2:32 PM
$LENZ I’ll post this again for those fearful of ‘too many adverse events’. Compare to vuity.
1 · Reply
tomorrowsglory
tomorrowsglory Feb. 22 at 10:14 PM
$LENZ Vizz is designed to treat one specific, widespread eye condition: presbyopia (age-related blurry near vision). While it targets only one condition, this condition impacts an estimated 1.8 to over 2 billion people worldwide.
1 · Reply
Max_Regards
Max_Regards Feb. 22 at 6:05 PM
$LENZ shorts and longs in constant contention on who is “right” and who is “wrong. Here is the thing, we can both make money, shorts have already made theirs. It’s too early to tell if success or failure can be claimed. If you’re long don’t listen to the noise from those that are short. June is my re-asses me nth for anyone wondering. We should have tangible data by then to really make a forecast of public adoption. Cheers and hope you all had a great weekend.
1 · Reply
UgoGreg
UgoGreg Feb. 21 at 3:55 PM
$LENZ https://youtu.be/ygBN8MilTyc
0 · Reply
NYTWben
NYTWben Feb. 21 at 4:58 AM
$LENZ https://www.gurufocus.com/news/8633604/lenz-therapeutics-lenz-attracts-positive-outlook-despite-fda-report-concerns?utm_source=perplexity
0 · Reply